Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
| ▸ | MAPT | P10636 | 3/20 | 0.68 |
| ▸ | MEN1 | O00255 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | VCAM1 | P19320 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.60 |
| ▸ | POLB | P06746 | 2/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | CRHBP | P24387 | 1/20 | 0.58 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31174170 | 1.00 | LMNA (0.77) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL6806851 | 0.92 | MAPK1 (0.77) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL144666 | 0.92 | MAPK1 (0.77) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL11714590 | 0.92 | LMNA (0.66) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL10808103 | 0.90 | LMNA (0.64) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL10477444 | 0.90 | LMNA (0.64) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL1625752 | 0.90 | LMNA (0.64) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL11025417 | 0.90 | TSHR (0.65) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL11714136 | 0.89 | L3MBTL1 (0.64) | LMNAMAPTMEN1KMT2AMAPK1 | |
| SCHEMBL441296 | 0.87 | LMNA (1.00) | LMNAMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027412-A | Photo-alignment material | 罗利克技术有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11634544-B2 | Photoaligning materials | Rolic Technologies AG (CH) | 2023-04-25 | — | — | US | disclosed |
| US-20210340330-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2021-11-04 | — | — | US | disclosed |
| CN-108912011-B | Photoalignment material | 罗立克科技股份公司 | 2021-09-24 | — | — | CN | disclosed |
| US-20200223984-A1 | PHOTOALIGNING MATERIALS | Rolic Technologies AG (CH) | 2020-07-16 | — | — | US | disclosed |
| US-10696795-B2 | Photoaligning materials | Rolic Technologies AG (CH) | 2020-06-30 | — | — | US | disclosed |
| EP-3374467-B1 | COMPOSITIONS OF PHOTO-ALIGNABLE MATERIALS | ROLIC TECH AG (CH) | 2020-04-15 | — | — | EP | disclosed |
| US-10558089-B2 | Photoalignment composition | ROLIC AG (CH) | 2020-02-11 | — | — | US | disclosed |
| EP-2222815-B1 | PHOTOALIGNMENT COMPOSITION | ROLIC TECH AG (CH) | 2019-05-29 | — | — | EP | disclosed |
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | ROLIC AG (CH) | 2019-02-19 | — | — | US | disclosed |
| EP-0133270-A1 | Reactive dyes | BASF Aktiengesellschaft (DE) | 1985-02-20 | — | — | EP | disclosed |
| EP-0119441-A2 | Reactive dyes with substituted 4-fluoropyridaz-6-one groups | BASF Aktiengesellschaft (DE) | 1984-09-26 | — | — | EP | disclosed |
| US-4473498-A | Water-soluble, fiber-reactive organic dyestuffs containing a β-chloro-ethylsulfonyl-methyl-benzoic acid amide group | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-09-25 | — | — | US | disclosed |
| EP-0040806-B1 | WATER-SOLUBLE, COLOURED COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1984-09-19 | — | — | EP | disclosed |
| EP-0012969-B1 | WATER-SOLUBLE FIBRE-REACTIVE COMPOUNDS AND THEIR USE IN FIBRE FINISHING,ESPECIALLY AS DYESTUFFS,AND DIHALOGENO-PYRIDAZONYL-CARBOXYLIC AND SULFONIC ACID HALIDES AND THEIR USE AS FIBRE-REACTIVE ANCHORS,AS WELL AS PROCESS FOR THE PREPARATION OF THESE COMPOUND | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-06-08 | — | — | EP | disclosed |
| EP-0040806-A2 | Water-soluble, coloured compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-12-02 | — | — | EP | disclosed |
| US-4242258-A | TETRAKISAZO, BLACK | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| EP-0012969-A2 | Water-soluble fibre-reactive compounds and their use in fibre finishing,especially as dyestuffs,and dihalogeno-pyridazonyl-carboxylic and sulfonic acid halides and their use as fibre-reactive anchors,as well as process for the preparation of these compound | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-07-09 | — | — | EP | disclosed |
| US-3960480-A | DYEING OR PRINTING | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-06-01 | — | — | US | disclosed |
| US-3959250-A | TEXTILE PRINTING LACQUERS, SYNTHETICS | CASSELLA FARBWERKE MAINKUR AKTIENGESELLSCHAFT (DT) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10208031-B2 | Photocrosslinkable materials comprising alicyclic group | DDC, ALAD, DYNC1LI1 | LMNA 590/4885MAPT 1424/4885MEN1 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.